Citadel Advisors’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Hold |
0
| – | – | – | 7547 |
|
|
2021
Q1 | – | Sell |
-706,864
| Closed | -$12M | – | 7094 |
|
|
2020
Q4 | $12M | Buy |
706,864
+665,524
| +1,610% | +$11.3M | ﹤0.01% | 1153 |
|
|
2020
Q3 | $195K | Sell |
41,340
-91,213
| -69% | -$430K | ﹤0.01% | 4100 |
|
|
2020
Q2 | $809K | Buy |
132,553
+3,617
| +3% | +$22.1K | ﹤0.01% | 3047 |
|
|
2020
Q1 | $292K | Sell |
128,936
-23,078
| -15% | -$52.3K | ﹤0.01% | 3819 |
|
|
2019
Q4 | $698K | Sell |
152,014
-67,756
| -31% | -$311K | ﹤0.01% | 3306 |
|
|
2019
Q3 | $851K | Buy |
219,770
+62,295
| +40% | +$241K | ﹤0.01% | 3059 |
|
|
2019
Q2 | $950K | Buy |
157,475
+130,783
| +490% | +$789K | ﹤0.01% | 3017 |
|
|
2019
Q1 | $358K | Sell |
26,692
-138,904
| -84% | -$1.86M | ﹤0.01% | 3611 |
|
|
2018
Q4 | $1.54M | Sell |
165,596
-79,739
| -33% | -$742K | ﹤0.01% | 2438 |
|
|
2018
Q3 | $3.42M | Buy |
245,335
+98,288
| +67% | +$1.37M | ﹤0.01% | 1806 |
|
|
2018
Q2 | $2.33M | Buy |
147,047
+71,683
| +95% | +$1.13M | ﹤0.01% | 2034 |
|
|
2018
Q1 | $1.3M | Sell |
75,364
-7,920
| -10% | -$136K | ﹤0.01% | 2265 |
|
|
2017
Q4 | $1.83M | Buy |
+83,284
| New | +$1.83M | ﹤0.01% | 1966 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 4293 |
|
|
2017
Q2 | – | Sell |
-153,932
| Closed | -$5.57M | – | 4361 |
|
|
2017
Q1 | $5.57M | Buy |
+153,932
| New | +$5.57M | 0.01% | 1164 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 4295 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 4268 |
|
|
2016
Q2 | – | Sell |
-9,065
| Closed | -$368K | – | 4099 |
|
|
2016
Q1 | $368K | Sell |
9,065
-256,902
| -97% | -$10.4M | ﹤0.01% | 2392 |
|
|
2015
Q4 | $11M | Buy |
265,967
+57,222
| +27% | +$2.37M | 0.01% | 806 |
|
|
2015
Q3 | $3.21M | Buy |
+208,745
| New | +$3.21M | ﹤0.01% | 1459 |
|
|
2015
Q1 | – | Sell |
-17,471
| Closed | -$472K | – | 4144 |
|
|
2014
Q4 | $472K | Buy |
17,471
+5,451
| +45% | +$147K | ﹤0.01% | 2591 |
|
|
2014
Q3 | $141K | Buy |
+12,020
| New | +$141K | ﹤0.01% | 2988 |
|